Systematic assessment of rare and de novo structural variants in 57 patient-parent trios using optical genome mapping
van der Sanden, B.; Vorimo, S.; Brunet, T.; Boughalem, A.; Jacob, M.; van Beek, R.; Kamping, E.; Rahikkala, E.; Kuismin, O.; Moilanen, J.; Pylkas, K.; Graf, E.; Loesecke, S.; Brugger, M.; Derderian, K.; Schatz, U.; Wagner, M.; Zech, M.; Schwaibold, E. M. C.; Distelmaier, F.; Borggraefe, I.; Vill, K.; Vissers, L. E. L. M.; Winkelmann, J.; Neveling, K.; Meitinger, T.; Mantere, T.; Trost, D.; Hoischen, A.
Show abstract
Next-generation sequencing has unraveled the genetic cause for many individuals with a rare disease, but a significant number of individuals remain undiagnosed using standard of care tests. It is anticipated that structural variants (SVs) have not been fully assessed in this context. Here, we performed optical genome mapping (OGM) for 57 trios and prioritized SVs using a two-step approach. First, we systematically identified all de novo SVs, and subsequently we studied all rare inherited SVs. Potential pathogenic SVs were confirmed using orthogonal methods. On average, we identified 6,289 SVs >500bp per proband, primarily insertions (69.8%) and deletions (27.1%). In total, we identified 13 de novo SVs, confirming a de novo mutation rate for large SVs of 0.23 or 1 in 4-5 cases. These de novo SVs impacted multiple (candidate) disease-associated genes, including NSF and FGF9. Additionally, on average per sample, we identified 11 rare inherited SVs overlapping with an established OMIM disease gene or its regulatory region, including a homozygous deletion affecting SCN9A causing congenital indifference to pain, a maternally inherited deletion in WWOX causing developmental and epileptic encephalopathy, and an interchromosomal insertion in the CMTX3 locus at Xq27.1 causing X-linked Charcot-Marie-Tooth disease. In total, we identified pathogenic SVs in three individuals and candidate disease-causing SVs in five other individuals. Overall, OGM enabled the accurate detection of challenging de novo and rare inherited SVs. Our results suggest a potential yield of disease-associated SVs in 5-14% of index cases, demonstrating that OGM can unravel previously hidden SVs in extensively tested individuals.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome Sequencing and Comprehensive Rare Variant Analysis of 465 Families with Neurodevelopmental Disorders 97%
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 96%
- Rare and de novo variants in 827 congenital diaphragmatic hernia probands implicate LONP1 and ALYREF as new candidate risk genes 95%
Similar papers in this journal
- Poison exon annotations improve the yield of clinically relevant variants in genomic diagnostic testing 97%
- Rare variants found in clinical gene panels illuminate the genetic and allelic architecture of orofacial clefting 96%
- Inherited variants in CHD3 demonstrate variable expressivity in Snijders Blok-Campeau syndrome 96%
Similar papers in this journal
- Exome sequencing as a first-tier test for copy number variant detection : retrospective evaluation and prospective screening in 2418 cases 94%
- A comparative medical genomics approach may facilitate the interpretation of rare missense variation 94%
- De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability 93%
Similar papers in this journal
- Re-evaluation and Re-analysis of 152 research exomes five years after the initial report reveals clinically relevant changes in 20% 96%
- BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations 96%
- Polycomb-associated and Trithorax-associated developmental conditions – phenotypic convergence and heterogeneity 94%
Similar papers in this journal
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 97%
- Biallelic truncation variants in ATP9A are associated with a novel autosomal recessive neurodevelopmental disorder 96%
- Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.